Blood Cancer Therapeutics Laboratory

Jake Shortt group
2021 group L-R: Front row - A/Prof Jake Shortt (Group Head),  Dr Daniella Brasacchio, Dr Olivia Susanto, Dr Matteo Costacurta, Dr Danielle Oh.  Back row -  Dr Gareth Gregory, Dr Sam Greenall, Ms Belinda Maher, Dr Mark Waltham

Donate to research in the
Blood Cancer Therapeutics Lab

Blood Cancer Therapeutics Laboratory's research seeks to evaluate novel ways to treat haematological malignancies, with a particular focus on leukaemia, lymphoma and multiple myeloma. By determining the molecular mechanisms underpinning specific blood cancers, we are developing novel therapeutic strategies for translation into clinical trials.  Our location within the Monash Health Translation Precinct uniquely places the laboratory in a position to develop our scientific discoveries from bench to bedside.

Major themes include, oncogenic transcription, epigenetic therapies, lymphoma genomics and rational targeting of the MYC oncogene.

Research news highlights

Group Head

Associate Professor Jake Shortt

Video presentation (1.33min) A/Prof Jake Shortt and Dr Sam Greenall talk about how they are working towards developing new therapies for haematological cancers. Published by BioCurate.

Meet the team


Other staff and students

Research Assistants

  • Dr Matteo Costacurta
  • Ms Belinda Maher

PhD Students and Consultant Haematologists

  • Dr Daniella Oh
  • Dr Maciej Tatarczuch